Tuodao Medical's Tuoling® Robotic-Assisted Radical Prostatectomy Marks Industry 'Gold Standard' Debut at The First Affiliated Hospital of Nanchang University

March 12,Professor Wang Gongxian, Director of the Department of Urology at the First Affiliated Hospital of Nanchang University (hereinafter referred to as “the First Affiliated Hospital of Nanchang University”) and Editor-in-Chief of the journal *Robotics Surgery*, led his team in leveraging the Tuoling system independently developed by Tuodao Medical^®Laparoscopic Surgical Robot: Successful Completion of a Case of Robot-Assisted Radical ProstatectomyThis surgical procedure is hailed as the "gold standard" for the surgical treatment of prostate cancer.

During the procedure, the surgical robot earned unanimous acclaim from the medical staff present for its precise dissection, stable performance, and smooth operation. Reportedly, this surgery marked the industry’s “gold standard” debut of the Tuodao laparoscopic surgical robot, representing a milestone that further underscores Tuodao Medical’s technological innovation capabilities and leading position in the field of surgical robotics.

According to reports, the patient undergoing this surgery was a 68-year-old male with long-standing difficulty in urination, clinically diagnosed with prostate cancer. Following preoperative discussions by Professor Wang Gongxian’s team, it was determined that the procedure posed significant technical challenges and involved the preservation of sexual function post-prostatectomy, thereby demanding extremely high precision and stability in surgical manipulation. The team ultimately reached a consensus to utilize the Tuodao system.^®Robotic-assisted laparoscopic radical prostatectomy.

During the procedure, Professor Wang Gongxian achieved seamless human-robot integration with the laparoscopic surgical robot. Leveraging Tuodao Medical’s self-developed 3D high-definition endoscope, the lesion was precisely identified. With the assistance of wristed instruments, the tissues surrounding the prostate were dissected and ligated, and the prostatic lesion was resected. The prostatic fascia was meticulously dissected while preserving the neurovascular bundles on both sides of the prostate. The urethra was rapidly anastomosed to reconstruct the bladder neck, ultimately leading to the successful completion of the surgery.

The robot’s high-definition 3D imaging, precise manipulation, and master-hand vibration filtering provide surgeons with enhanced tissue discrimination and refined operational control. Intraoperative blood loss was only 100 mL, demonstrating significantly superior surgical outcomes compared to conventional laparoscopic surgery.

Urethral dissection, clear anatomical delineation, and adequate protection of surrounding nerves

Postoperative,Professor Wang Gongxian gave high praise to this surgery, stating that currently, domestically developed endoscopic surgical robots can meet the needs of various urological procedures. He also proposed further collaborative innovation with domestic robotics companies in the future, aiming to bring "Intelligent Manufacturing in China" to the global stage.Dr. Cheng Min, Chairman of Tuodao Medical, stated, “Tuodao is highly committed to collaborating with academic opinion leaders in medical-engineering partnerships, fostering medical innovation among Chinese physicians, empowering minimally invasive surgical procedures, and ultimately benefiting patients.”

Tuodao^®Laparoscopic surgical robots have demonstrated their application value and potential. With continuous technological advancements and the expansion of clinical applications, they are poised to play a key role in more surgical procedures, helping to improve clinical outcomes and reduce patient trauma. Recently, Tuodao Medical^®Laparoscopic surgical robots will sequentially initiate clinical trials in departments such as gynecology and general surgery, further empowering precise clinical procedures!

Tuoling^®Endoscopic surgical robots consist of a surgeon console, a patient-side surgical platform, and an image processing platform. Compared with traditional endoscopy, Tuoling^®The 8-degree-of-freedom control arms of the laparoscopic surgical robot provide surgeons with an exceptionally dexterous operational experience. The proprietary 3D electronic endoscope delivers stereoscopic imaging with rich depth-of-field information, offering surgeons meticulous, immersive visual feedback. High-precision master-slave control algorithms empower surgeons to perform delicate maneuvers with ease, enabling minimally invasive and precise lesion resection. Intelligent human-machine interaction design, featuring automated functions such as one-click positioning, simplifies user operations and enhances surgical efficiency. A comprehensive suite of 15 specialized instruments meets the routine clinical and customized needs across various medical departments.

Professor Wang Gongxian

Level 2 Professor | Chief Physician

Graduate Supervisor | Doctoral Supervisor | Postdoctoral Supervisor

Recipient of the State Council Special Allowance

Jiangxi Province Outstanding Contribution Talent
Jiangxi Province High-Level Academic Leader
Director, Jiangxi Provincial Institute of Urology
Director, Jiangxi Provincial Clinical Medical Research Center for Urology
Deputy Head, Robotics Group, Urology Branch, Chinese Medical Association
Deputy Head, Robotics Group, Urology Branch of the Chinese Medical Doctor Association
National Standing Committee Member, Urology Branch, Chinese Medical Doctor Association
National Standing Committee Member, Medical Robotics Branch of the Chinese Medical Doctor Association
Executive Director, International Urolithiasis Alliance
Editor-in-Chief of the Journal of Robotic Surgery
The Global Pioneer of Transvesical RARP
In 2017, the number of single-console robotic surgeries set a world record, ranking first globally.
2020: Won the National Robotics Group “Kongming Cup Award”
First Prize of Jiangxi Provincial Science and Technology Progress Award in 2023

The team led by Professor Wang Gongxian at the First Affiliated Hospital of Nanchang University is a renowned group of experts in the medical field. With Professor Wang as its core, the team brings together national-level medical talents such as Professor Fu Bin and Dr. Zhang Cheng, achieving continuous breakthroughs in medical research and clinical practice:In 2014, pioneered a new era of robotic surgery in Jiangxi Province; in 2017, broke the world record and ranked first globally for the highest annual volume of robotic surgeries performed on a single system; in 2020, spearheaded the establishment of China’s first Journal of Robotic Surgery; in 2023, awarded the First Prize of Jiangxi Provincial Science and Technology Progress Award., with remarkable achievements... All members of Professor Wang Gongxian’s team possess exceptional medical expertise and a rigorous professional attitude, dedicated to providing patients with precise and efficient diagnostic and therapeutic services. The team has demonstrated outstanding performance across multiple medical fields, earning deep trust and high acclaim from patients.

Tuodao Medical specializes in the design, research and development, and clinical implementation of surgical robots. It is committed to providing robotic solutions for medical users across all specialties, empowering the development of the smart healthcare industry through technological innovation.

Leveraging cutting-edge core technologies such as data algorithms, artificial intelligence, and precision intelligent control, Tuodao Medical has meticulously developed a core technology platform for surgical robots. The company has strategically laid out its presence in five major surgical robot sectors: orthopedics, laparoscopy, percutaneous puncture, natural orifice transluminal endoscopic surgery (NOTES), and medical imaging equipment. By deeply cultivating diverse clinical departments and surgical applications, Tuodao Medical’s surgical robot product pipeline now covers orthopedics, general surgery, gynecology, urology, pulmonology, radiology, and other specialties.

In the future, upholding its corporate mission of “Making Surgery Simpler, Making Life Healthier,” Tuodao Medical will collaborate with industry and ecosystem partners to achieve a comprehensive product portfolio layout across all medical specialties, build an integrated remote smart healthcare center, and jointly shape the future of human health.

In 2022, Tuodao Medical's TuoShou^®Orthopedic surgical robots and Daoying mobile C-arm X-ray machines have been approved for market launch; in 2023, Daoying 3D mobile C-arm X-ray machines and Tuoying^®Mobile C-arm X-ray Machine and Tuodao Surgery^®Percutaneous puncture surgical robot obtained certification and achieved commercialization. In 2024, the core product Tuoling^®Laparoscopic surgical robots have officially entered human clinical trials. We believe that AI-empowered healthcare will benefit a vast number of patients and promote healthier lives.